Citius Oncology, Inc. (CTOR) stock
Close on Nov 12, 2026Market cap $48.56MP/E –Yield –
Citius Oncology statistics
63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 12, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.28
- 2.38
Share statisticsIndustry
- Shares Change (QoQ)
- 13.7%
- 0.48%
- Float
- 21M
- 49M
- Shares Held by Insiders
- 77.6%
- 12.1%
- Shares Held by Institutions
- 15.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 201,913
- –
- Short Interest Change
- -11.2%
- -0.80%
- Short % of Float
- 0.97%
- 9.06%
- Short % of Shares Outstanding
- 0.22%
- 6.30%
- Days to Cover
- 1.19
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1.83
- –
- 52-Week Low
- $0.49
- –
- 20-Day Moving Average
- $0.61
- –
- 50-Day Moving Average
- $0.80
- –
- 200-Day Moving Average
- $0.81
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- 1.44%
- -0.58%
- Price Change (1 Month)
- -29.9%
- -0.28%
- Price Change (3 Months)
- -32.9%
- -17.1%
- Price Change (6 Months)
- -43.8%
- -20.1%
- Price Change (YTD)
- -44.5%
- -20.1%
- Price Change (1 Year)
- -61.2%
- -19.3%
- Price Change (3 Years)
- -94.9%
- -22.2%
- Average Volume (10 Days)
- 171,544
- –
- Average Volume (20 Days)
- 156,166
- –
- Average Volume (90 Days)
- 109,882
- –
- Relative Volume
- 0.42
- 0.73
- Relative Strength Index (14)
- 37.7
- 47.7
- Volatility (1 Year)
- 94.5%
- 80.2%
- Beta (5 Years)
- 1.09
- 1.08
Returns on capitalIndustry
- Return on Equity (ROE)
- -126.6%
- -51.3%
- Return on Assets (ROA)
- -45.2%
- -40.7%
- Return on Invested Capital (ROIC)
- -119.3%
- -32.9%
- Return on Capital Employed (ROCE)
- -88.7%
- -38.1%
Financial positionIndustry
- Current Ratio
- 0.73
- 3.30
- Quick Ratio
- 0.29
- 2.40
- Debt / Equity
- 0.16
- 0.50
- Interest Coverage
- -128.56
- -6.35
EfficiencyIndustry
- WACC
- 9.71%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$45.87M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $10.15M
- $16.56M
- Net Cash Per Share
- $0.11
- $0.71
- Equity (Book Value)
- $40.39M
- $52.23M
- Book Value Per Share
- $0.43
- $1.50
- Tangible Book Value
- $40.39M
- $26.10M
- Working Capital
- -$16.08M
- $78.41M
Dividends and yieldsIndustry
- Earnings Yield
- -89.3%
- -20.1%
- Buyback Yield
- -58.6%
- -0.69%
- Shareholder Yield
- -58.6%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $367.88K
- $2.98M
- Income Tax
- $189.92K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -2.45
- 0.31
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CTOR | S&P 500 | Difference | CTOR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -35.7% | -2.7% | −33.0 pts | ||
| 3 months | -35.6% | -1.7% | −33.9 pts | ||
| Year to date | -47.8% | +11.9% | −59.7 pts | ||
| 1 year | -61.0% | +12.0% | −73.0 pts | ||
| 3 years | -95.2% | +78.2% | −173.4 pts | -63.7% | +21.2% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M CTOR shares were sold short on Oct 30, 2026, down 11.2% from the previous report, or 0.97% of the shares available to trade. At recent volumes it would take 1.2 days to buy them back. Over the last 20 sessions, 23.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 201,913 | -11.2% | 170,140 | 1.2 |
| Oct 15, 2026 | 227,455 | -21.5% | 84,753 | 2.7 |
| Sep 30, 2026 | 289,717 | -43.1% | 129,388 | 2.2 |
| Sep 15, 2026 | 509,543 | +8.7% | 73,934 | 6.9 |
| Aug 31, 2026 | 468,965 | +3.7% | 64,312 | 7.3 |
| Aug 14, 2026 | 452,413 | +13.3% | 194,984 | 2.3 |
| Jul 31, 2026 | 399,412 | +9.4% | 64,468 | 6.2 |
| Jul 15, 2026 | 365,150 | -19.5% | 44,211 | 8.3 |
| Jun 30, 2026 | 453,353 | -8.8% | 39,787 | 11.4 |
| Jun 15, 2026 | 497,356 | -21.3% | 77,996 | 6.4 |
| May 29, 2026 | 631,733 | +30.5% | 65,907 | 9.6 |
| May 15, 2026 | 484,262 | -26.1% | 108,400 | 4.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?